1. Ejaculatory disorders

   • Uwe Hartmann
   • Marcel D. Waldinger

   Invited Editorial 01 June 2005 Pages: 67 - 67

2. Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping

   • Emmanuele A. Jannini
   • Andrea Lenzi

   Topic Paper 18 May 2005 Pages: 68 - 75

   

3. Retarded ejaculation in men: an overview of psychological and neurobiological insights

   • Marcel D. Waldinger
   • Dave H. Schweitzer

   Topic Paper 04 June 2005 Pages: 76 - 81

4. Psychophysiology of ejaculatory function and dysfunction

   • David L. Rowland

   Topic Paper 10 May 2005 Pages: 82 - 88

5. Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome

   • Stanley E. Althof

   Topic Paper 01 June 2005 Pages: 89 - 92

6. Cognitive and partner-related factors in rapid ejaculation: Differences between dysfunctional and functional men.

   • U. Hartmann
   • M. Schedlowski
   • T. H. C. Krüger

   Topic Paper 10 June 2005 Pages: 93 - 101

   

7. Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment

   • Marcel D. Waldinger

   Topic Paper 02 June 2005 Pages: 102 - 108

   

8. Central nervous system control of ejaculation

   • Gert Holstege

   Topic Paper 04 May 2005 Pages: 109 - 114

9. Animal models of premature and retarded ejaculation

   • Marcel D. Waldinger
   • Berend Olivier

   Topic Paper 07 June 2005 Pages: 115 - 118

10. Spinal cord control of ejaculation

    • Julien Allard
    • William A. Truitt
    • Lique M. Coolen

    Topic Paper 10 June 2005 Pages: 119 - 126

    

11. Guidelines for the pharmacotherapy of premature ejaculation

    • Pierre Assalian

    Topic Paper 12 April 2005 Pages: 127 - 129

12. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans

    • Tillmann H. C. Krüger
    • Uwe Hartmann
    • Manfred Schedlowski

    Topic Paper 12 May 2005 Pages: 130 - 138

    

13. Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms—a placebo-controlled, double-blind, multicenter trial

    • N. Lopatkin
    • A. Sivkov
    • U. Engelmann

    Free Paper 01 June 2005 Pages: 139 - 146

    

14. Piboserod (SB 207266), a selective 5-HT₄ receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscle

    • B. Darblade
    • D. Behr-Roussel
    • F. Giuliano

    Free Paper 18 May 2005 Pages: 147 - 151